| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 7 May 2026 | 22 Apr 2026 |
| Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/05/2026 inter alia to consider and approve the Audited Standalone and Consolidated Financial Results of the Company for the quarter and year ended March 31 2026 and recommend dividend if any. Approval of the Audited Financial Statements for the quarter and year ended March 31, 2026 and recommend Final Divided of Rs. 18/- per equity share i.e. 900% of the Face Value of Rs. 2/- each fully paid up for the Financial Year ended March 31, 2026 (As Per BSE Announcement Dated on:07.05.2026) | ||
| Board Meeting | 12 Feb 2026 | 28 Jan 2026 |
| Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31 2025. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and nine months ended December 31, 2025. Outcome of the Board Meeting for Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Nine Months ended December 31, 2025. (As Per BSE Announcement Dated on 12.02.2026) | ||
| Board Meeting | 6 Jan 2026 | 6 Jan 2026 |
| Appointment of Mr. Anand Kripalu as an Additional Director (Non-Executive, Independent) effective February 01, 2026 and as an Independent Director for a term of five consecutive years with effect from February 01, 2026 | ||
| Board Meeting | 6 Nov 2025 | 22 Oct 2025 |
| Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2025 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30 2025. Outcome of the Board Meeting for Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter and Half Year ended September 30, 2025. (As Per BSE Announcement Dated on 06.11.2025) | ||
| Board Meeting | 5 Aug 2025 | 21 Jul 2025 |
| Lupin Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/08/2025 inter alia to consider and approve Unaudited Standalone and Consolidated Financial Results of the Company for the Quarter Ended June 30 2025. Approval of the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter ended June 30, 2025. (As Per BSE Announcement Dated on: 05.08.2025) | ||
As per the terms of agreement, Lupin will hold exclusive rights for commercialisation and distribution of bofanglutide in India.
Here are some of the stocks that may see significant price movement today: Lupin, Bandhan Bank, Jubilant Foodworks, etc.
Here are some of the stocks that may see significant price movement today: HCL Tech, Bharti Airtel, Amber Enterprises, etc.
The business said that its revenue from operations registered a growth of 24.20% y-o-y at ₹7,047.50 Crore.
The inspection was held between September 8 and 16. Lupin did not disclose the details of the observations but said it would respond within the required timeline.
The launch aligns with Lupin’s strategic push into injectables, biosimilars, and inhalation therapies, supported by robust R&D and manufacturing capabilities
Here are some of the stocks that may see significant price movement today: Bharti Airtel, Torrent Power, Lupin Limited, etc.
This is eligible for 180 days of generic drug exclusivity. The company will manufacture the product at its facility situated in India.
Here are some of the stocks that may see significant price movement today: Godrej Properties, SBI Cards, Hyudai India, etc.
The tablets will be made at the company’s Goa facility, a site that has previously cleared global regulatory inspections and supports Lupin’s key exports.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, PMS SEBI Regn. No: INP000002213, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
